G1 Therapeutics Inc banner

G1 Therapeutics Inc
NASDAQ:GTHX

Watchlist Manager
G1 Therapeutics Inc Logo
G1 Therapeutics Inc
NASDAQ:GTHX
Watchlist
Price: 7.15 USD Market Closed
Market Cap: $377.2m

Wall St Price Targets

GTHX Price Targets Summary
G1 Therapeutics Inc

There are no price targets for GTHX.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
G1 Therapeutics Inc Competitors:
Price Targets
ELAN
Elanco Animal Health Inc
27% Upside
PTCT
PTC Therapeutics Inc
10% Upside

Revenue
Forecast

88% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
88% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 88%. The projected CAGR for the next 3 years is 10%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for G1 Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for G1 Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for G1 Therapeutics Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GTHX's stock price target?
Not Available

GTHX does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for G1 Therapeutics Inc?
Projected CAGR
10%

Over the last 8 years, the compound annual growth rate for Revenue has been 88%. The projected CAGR for the next 3 years is 10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett